<html>
<head>
<title>Heart Failure and ACE Inhibitor</title>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
<script language="JavaScript">
<!--
function MM_goToURL() { //v3.0
  var i, args=MM_goToURL.arguments; document.MM_returnValue = false;
  for (i=0; i<(args.length-1); i+=2) eval(args[i]+".location='"+args[i+1]+"'");
}
//-->
</script>
</head>

<body bgcolor="#EBFBFE" text="#000000">
<ul>
  <li><font size="-1" face="Verdana, Arial, Helvetica, sans-serif" color="660033">Patients 
    with left ventricular ejection fraction&lt;36% treated with ACE inhibitors 
    had a substantial reduction in mortality, hospitalization for CHF and reinfarction 
    (table 1) as compared to placebo. (<a href="../Original%20papers/Ace%20Inhibitor%20and%20Heart%20Failure_OP.html#Flathers" onClick="MM_goToURL('parent.frames[\'main_banner\']','../Banners/PubMed.htm','parent.frames[\'main_content\']','../Original%20papers/Heart%20Failure%20and%20ACE%20Inhibitor_content.html#Flather');return document.MM_returnValue">Flather 
    2000</a>) </font></li>
  <li><font size="-1" face="Verdana, Arial, Helvetica, sans-serif" color="660033">High 
    dose ACE inhibitor (lisinopril- 30mg) reduced combined outcomes of mortality 
    and hospitalization in 3 years in patients with heart failure as compared 
    to low dose ACE inhibitor (lisinopril 2.5-5mg) (table 2). (<a href="../Original%20papers/Ace%20Inhibitor%20and%20Heart%20Failure_OP.html#Packer" onClick="MM_goToURL('parent.frames[\'main_banner\']','../Banners/PubMed.htm','parent.frames[\'main_content\']','../Original%20papers/Heart%20Failure%20and%20ACE%20Inhibitor_content.html#Packer');return document.MM_returnValue">Packer 
    1999</a>)</font></li>
  <li><font size="-1" face="Verdana, Arial, Helvetica, sans-serif" color="660033">Benefits 
    were observed early after the start of therapy and persisted long term. (<a href="../Original%20papers/Ace%20Inhibitor%20and%20Heart%20Failure_OP.html#Flathers" onClick="MM_goToURL('parent.frames[\'main_banner\']','../Banners/PubMed.htm','parent.frames[\'main_content\']','../Original%20papers/Heart%20Failure%20and%20ACE%20Inhibitor_content.html#Flather');return document.MM_returnValue">Flather 
    2000</a>)</font> </li>
</ul>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2" color="660033">Table 
  1: Effect of ACE inhibitors vs placebo on patients with heart failure on morbidity 
  and mortality</font></p>
<table border="1" cellpadding="0" cellspacing="0">
  <tr align="center" valign="middle"> 
    <td width="44" bgcolor="#FFFFE1"><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">Study</font></b></td>
    <td width="132" bgcolor="#FFFFE1"><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">Population</font></b></td>
    <td width="87" bgcolor="#FFFFE1"><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">Intervention</font></b></td>
    <td width="61" bgcolor="#FFFFE1"><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">Study 
      type</font></b></td>
    <td width="82" bgcolor="#FFFFE1"><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">Mean 
      follow-up (range)</font></b></td>
    <td width="84" bgcolor="#FFFFE1"><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">Outcome</font></b></td>
    <td width="123" bgcolor="#FFFFE1"><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">Odds 
      ratio(95% CI)</font></b></td>
  </tr>
  <tr align="center" valign="middle"> 
    <td rowspan="3" width="44" bgcolor="#FEE0E9"><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">Flather 
      2000</font></td>
    <td rowspan="3" width="132" bgcolor="#FEE0E9"><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">5966 
      patients with recent MI and clinical manifestations of congestive heart 
      failure and 6797 patients with congestive heart failure*</font></td>
    <td rowspan="3" width="87" bgcolor="#FEE0E9"><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">Various 
      ACE inhibitors versus placebo</font></td>
    <td rowspan="3" width="61" bgcolor="#FEE0E9"><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">Systematic 
      review</font></td>
    <td rowspan="3" width="82" bgcolor="#FEE0E9"><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">35 
      (15-42) weeks</font></td>
    <td width="84" bgcolor="#FEE0E9"><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">Death </font></b></td>
    <td width="123" align="center" bgcolor="#FEE0E9"><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">0.74 
      (0.66-0.83)</font></b></td>
  </tr>
  <tr> 
    <td width="84" bgcolor="#FEE0E9"><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">Hospitalization</font></b></td>
    <td width="123" align="center" bgcolor="#FEE0E9"><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">0.73 
      (0.63-0.85)</font></b></td>
  </tr>
  <tr> 
    <td width="84" bgcolor="#FEE0E9"><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">Non 
      fatal MI</font></b></td>
    <td width="123" align="center" bgcolor="#FEE0E9"><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">0.80 
      (0.69-0.94)</font></b></td>
  </tr>
</table>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="660033">* 
      90% NYHA class II and III</font></td>
  </tr>
</table>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2" color="660033">Table 
  2: Effect of high dose vs low dose ACE inhibitors on patients with heart failure 
  on morbidity and mortality</font></p>
<table border="1" cellpadding="0" cellspacing="0" width="99%">
  <tr align="center"> 
    <td rowspan="2" bgcolor="#FFFFE1" width="9%"><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">Study 
      </font></b></td>
    <td rowspan="2" bgcolor="#FFFFE1" width="12%"><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">Population</font></b></td>
    <td rowspan="2" bgcolor="#FFFFE1" width="12%"><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">Intervention 
      </font></b></td>
    <td rowspan="2" bgcolor="#FFFFE1" width="7%"><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">Study 
      type</font></b></td>
    <td rowspan="2" bgcolor="#FFFFE1" width="18%"><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">Outcomes 
      </font></b></td>
    <td colspan="2" bgcolor="#FFFFE1" height="22"><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">Events 
      (%) </font></b></td>
    <td rowspan="2" bgcolor="#FFFFE1" width="15%"> 
      <p><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">Relative 
        Risk <br>
        (95% CI) </font></b></p>
      </td>
    <td rowspan="2" bgcolor="#FFFFE1" width="12%"> 
      <p><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">Relative 
        Risk Reduction <br>
        (95% CI) </font></b></p>
      </td>
  </tr>
  <tr> 
    <td bgcolor="#FFFFE1" align="center" width="8%" height="45"><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">Low 
      dose lisinopril </font></b></td>
    <td bgcolor="#FFFFE1" align="center" width="7%" height="45"><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">High 
      dose lisinopril </font></b></td>
  </tr>
  <tr> 
    <td rowspan="3" bgcolor="#FEE0E9" width="9%" valign="middle" align="center"><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">Packer  
      1999 (ATLAS)</font></td>
    <td rowspan="3" bgcolor="#FEE0E9" width="12%" valign="middle" align="center"><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">3164 
      patients with heart failure*, mean age 63.6 yrs, 80% male</font></td>
    <td rowspan="3" bgcolor="#FEE0E9" width="12%" valign="middle" align="center"><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">lisinopril 
      <br>
      2.5-5mg/d vs 30mg/d</font></td>
    <td rowspan="3" bgcolor="#FEE0E9" width="7%"><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">Double 
      blind RCT, median follow up 45.7 months</font></td>
    <td bgcolor="#FEE0E9" width="18%" height="30"><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">All 
      cause mortality¶</font></b></td>
    <td bgcolor="#FEE0E9" width="8%" height="30" align="center" valign="middle"><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">717 
      (44.9%)</font></td>
    <td bgcolor="#FEE0E9" width="7%" height="30" align="center" valign="middle"><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">666 
      (42.5%)</font></td>
    <td bgcolor="#FEE0E9" width="15%" height="30" align="center"><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">0.92 
      <br>
      (0.82-1.03)</font></b></td>
    <td bgcolor="#FEE0E9" width="12%" height="30" align="center"><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">8% 
      <br>
      (0-18)</font></td>
  </tr>
  <tr> 
    <td bgcolor="#FEE0E9" width="18%" height="33"><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">All 
      cause mortality+<br>
      hospitalization¶¶</font></b></td>
    <td bgcolor="#FEE0E9" width="8%" height="33" align="center" valign="middle"><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">1338 
      (83.8%)</font></td>
    <td bgcolor="#FEE0E9" width="7%" height="33" align="center" valign="middle"><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">1250 
      (79.7%)</font></td>
    <td bgcolor="#FEE0E9" width="15%" height="33" align="center"><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">0.88 
      <br>
      (0.82-0.96)</font></b></td>
    <td bgcolor="#FEE0E9" width="12%" height="33" align="center"><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">12% 
      <br>
      (4-18)</font></td>
  </tr>
  <tr> 
    <td bgcolor="#FEE0E9" width="18%" height="45"><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">Cardiovascular 
      (CV) mortality plus CV hospitalization¶¶</font></b></td>
    <td bgcolor="#FEE0E9" width="8%" height="45" align="center" valign="middle"><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">1161 
      (72.7%)</font></td>
    <td bgcolor="#FEE0E9" width="7%" height="45" align="center" valign="middle"><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">1088 
      (69.4%)</font></td>
    <td bgcolor="#FEE0E9" width="15%" height="45" align="center"><b><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">0.91 
      <br>
      (0.84-0.99)</font></b></td>
    <td bgcolor="#FEE0E9" width="12%" height="45" align="center"><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="663333">9% 
      <br>
      (1-16)</font></td>
  </tr>
</table>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td><font face="Verdana, Arial, Helvetica, sans-serif" size="1" color="660033">*NYHA 
      class II, III or IV despite use of diuretics for <img src="greaterthansign.gif" width="4" height="6"> 
      2 months and left ventricular ejection fraction <img src="lessthansign.gif" width="5" height="7"> 
      30% &nbsp;&nbsp;<br>
      &para; primary endpoint<br>
      &para;&para; secondary endpoints</font> </td>
  </tr>
</table>
</body>
</html>
